Martin Shkreli and Insulin: What to Know About Drug Pricing, Daraprim, and Broader Healthcare Context
Pharma-Affordability
This article offers an evergreen, factual overview of Martin Shkreli’s role in the 2015 Daraprim price increase and why it is often discussed alongside insulin, access, and dr...
Open article